XML 74 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Intangible Assets
 6 Months Ended
Apr. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Intangible Assets

Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance at October 31, 2019
1,765.4

 
663.5

 
2,428.9

Current period additions
—

 
1.9

 
1.9

Foreign currency translation adjustment
(27.2
)
 
(3.6
)
 
(30.8
)
Balance at April 30, 2020
$
1,738.2

 
$
661.8

 
$
2,400.0



The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill, evaluates and tests goodwill balances for impairment in accordance with related accounting standards. The Company performed an annual impairment assessment in third quarter of fiscal 2019, and its analysis indicated that there was no impairment of goodwill in reporting units.
Other Intangible Assets
 
April 30, 2020
 
October 31, 2019
 
 
(In millions)
Gross Carrying
Amount
 
Accumulated
Amortization
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Weighted Average Amortization Period (in years)
Intangible assets with definite lives:
 
 
 
 
 
 
 
 
 
Trademarks
$
147.7

 
$
32.3

 
$
148.5

 
$
27.3

 
14
Composite intangible asset
1,061.9

 
177.0

 
1,061.9

 
141.6

 
15
Technology
399.3

 
236.2

 
399.9

 
221.2

 
11
Customer relationships
357.7

 
203.5

 
357.6

 
194.0

 
13
License and distribution rights and other
27.9

 
16.7

 
27.9

 
15.3

 
11
 
1,994.5

 
$
665.7

 
1,995.8

 
$
599.4

 
14
Less: accumulated amortization and translation
665.7

 
 
 
599.4

 
 
 
 
Intangible assets with definite lives, net
1,328.8

 
 
 
1,396.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangible assets with indefinite lives, net (1)
8.9

 
 
 
8.9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total other intangibles, net
$
1,337.7

 
 
 
$
1,405.3

 
 
 
 

(1) Intangible assets with indefinite lives include technology and trademarks.
Balances include foreign currency translation adjustments.







As of April 30, 2020, the estimation of amortization expenses for intangible assets with definite lives is as follows:
Fiscal years:
(In millions)
Remainder of 2020
$
67.4

2021
134.6

2022
132.7

2023
130.5

2024
126.2

Thereafter
737.4

Total remaining amortization for intangible assets with definite lives
$
1,328.8


The Company assesses indefinite-lived intangible assets annually during the fiscal third quarter and both indefinite-lived and definite-lived intangible assets, when an event occurs or change in circumstances indicate that the carrying amount of an intangible asset may not be recoverable, in accordance with related accounting standards. The Company performed an annual impairment assessment in third quarter of fiscal 2019 and did not recognize any material intangible asset impairment charges.
Given the general deterioration in economic and market conditions surrounding the COVID-19 pandemic, the Company considered the impact that the COVID-19 pandemic may have on its near and long-term forecasts and determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts, and therefore the Company determined that there was no impairment to either its goodwill, definite-lived or indefinite-lived intangible assets at April 30, 2020.